15632 Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: Patheon 

Pharmaceuticals, Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic class and applicants 

therefore may file written comments or 

objections to the issuance of the 

proposed registration in accordance 

with 21 CFR 1301.33(a) on or before 

May 26, 2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on 

December 11, 2014, Patheon 

Pharmaceuticals, Inc., 2110 E. Galbraith 

Road, Cincinnati, Ohio 45237 applied to 

be registered as a bulk manufacturer of 

gamma hydroxybutyric acid (2010), a 

basic class of nonnarcotic controlled 

substance in schedule I. 

The company plans to manufacture 

the listed controlled substance for 

distribution to its customers. 

Dated: March 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–06733 Filed 3–23–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: Penick 

Corporation 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.33(a) on 

or before May 26, 2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart, R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on 

February 26, 2014, Penick Corporation, 

33 Industrial Park Road, Pennsville, 

New Jersey 08070, applied to be 

registered as a bulk manufacturer of the 

following basic classes of controlled 

substances: 

Controlled substance Schedule 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Ecgonine (9180) ........................... II 

Hydrocodone (9193) ..................... II 

Morphine (9300) ........................... II 

Oripavine (9330) ........................... II 

Controlled substance Schedule 

Thebaine (9333) ........................... II 

Opium tincture (9630) .................. II 

Oxymorphone (9652) ................... II 

The company plans to manufacture 

the above-listed controlled substances 

as bulk controlled substance 

intermediates for distribution to its 

customers. 

Dated: March 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–06734 Filed 3–23–15; 8:45 am] 

BILLING CODE 4410–09–P 

LIBRARY OF CONGRESS 

Copyright Royalty Board 

[Docket No. 14–CRB–0006 DART SR (CO/ 

FA) 2013] 

Distribution of the 2013 Digital Audio 

Recording Technology Royalty Funds 

AGENCY: Copyright Royalty Board, 

Library of Congress. 

ACTION: Notice announcing 

commencement of proceeding with 

request for Petitions to Participate and 

comments on intention to conduct 

paper proceeding. 

SUMMARY: The Copyright Royalty Board 

is announcing the commencement of a 

proceeding to determine the distribution 

of the digital audio recording 

technology royalty fees in the 2013 

Sound Recordings Fund (Copyright 

Owners and Featured Recording Artists 

Subfunds). The Board is also 

announcing the date by which a party 

who wishes to participate in this 

proceeding must file its Petition to 

Participate and the accompanying $150 

filing fee, if applicable. Finally, the 

Board is announcing the Copyright 

Royalty Judges’ intention to conduct a 

paper proceeding. 

DATES: Petitions to Participate, 

comments on the intention to conduct a 

paper proceeding, and applicable filing 

fee are due no later than April 23, 2015. 

ADDRESSES: An original, five copies, and 

an electronic copy in Portable 

Document Format (PDF) on a CD of the 

Petition to Participate, along with the 

$150 filing fee, if applicable, may be 

delivered to the Copyright Royalty 

Board by either mail or hand delivery. 

Petitions to Participate and the $150 

filing fee may not be delivered by an 

overnight delivery service other than the 

U.S. Postal Service Express Mail. If by 

mail (including overnight delivery), 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices 15633 

1Similarly, the statute prescribes that the royalty 

fees allocated to the Musical Works Fund be 

divided equally between two subfunds, the 

Publishers Subfund and the Writers Subfund. 17 

U.S.C. 1006(b)(2). 

2 79 FR 60185. 

3The Copyright Royalty Judge Program Technical 

Corrections Act, Public Law 109–303, changed the 

amount from $10,000 to $1,000. 

Petitions to Participate, along with the 

$150 filing fee, must be addressed to: 

Copyright Royalty Board, P.O. 70977, 

Washington, DC 20024–0977. If handdelivered by a private party, Petitions to 

Participate, along with the $150 filing 

fee, must be brought to the Library of 

Congress, James Madison Memorial 

Building, LM–401, 101 Independence 

Avenue SE, Washington, DC 20559– 

6000. If delivered by a commercial 

courier, Petitions to Participate, along 

with the $150 filing fee, must be 

delivered to the Congressional Courier 

Acceptance Site, located at 2nd and D 

Street, NE., Washington, DC. The 

envelope must be addressed to: 

Copyright Royalty Board, Library of 

Congress, James Madison Memorial 

Building, LM–403, 101 Independence 

Avenue SE, Washington, DC 20559– 

6000. 

FOR FURTHER INFORMATION CONTACT: 

LaKeshia Keys, CRB Program Specialist. 

Telephone: (202) 707–7658 or email at 

crb@loc.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Audio Home Recording Act of 

1992 (the ‘‘AHRA’’), Public Law 102– 

563, requires manufacturers and 

importers to pay royalties on digital 

audio recording devices and media that 

are distributed in the United States. 17 

U.S.C. 1003. These royalties are 

deposited with the Copyright Office for 

further distribution among interested 

copyright parties by the Copyright 

Royalty Judges (‘‘Judges’’), provided that 

the interested copyright parties file a 

claim with the Copyright Royalty Board 

(CRB) each year during the months of 

January and February. 17 U.S.C. 1005, 

1007. 

The AHRA provides that the royalties 

are divided between two funds: the 

Sound Recordings Fund and the 

Musical Works Fund. The Sound 

Recordings Fund receives 662⁄3% of the 

royalties and the Musical Works Fund 

receives the remaining 331⁄3%. These 

fees are allocated further to specific 

subfunds. 

The Sound Recordings Fund consists 

of four subfunds: the Featured Artists 

Subfund, the Copyright Owners 

Subfund, the Nonfeatured Musicians 

Subfund, and the Nonfeatured Vocalists 

Subfund. The royalty fees allocated to 

the Sound Recordings Fund are divided 

among these four subfunds according to 

the percentages set out in section 1006 

of the Copyright Act. 17 U.S.C. 

1006(b)(1).1 Distribution of these fees 

may occur in one of two ways. The 

interested copyright parties within each 

subfund may either negotiate the terms 

of a settlement as to the division of 

royalty funds, or the Judges may 

conduct a proceeding to determine the 

distribution of the royalties that remain 

in controversy in each subfund. See 17 

U.S.C. 1006(c). 

On August 18, 2014, the CRB received 

a motion from the Alliance of Artists 

and Recording Companies (AARC) 

asking the Judges to authorize a partial 

distribution of 98% of the 2013 digital 

audio recording technology (‘‘DART’’) 

Sound Recordings Fund (Copyright 

Owners and Featured Recording Artists 

subfunds). The CRB published notice of 

the settlement and a solicitation of 

comments in the Federal Register on 

October 6, 2014.2 On December 19, 

2014, the Judges granted the motion, 

finding that there was no reasonable 

objection to AARC’s proposed partial 

distribution. See Order Granting 

AARC’s Request for Partial Distribution 

of Royalties from the 2013 DART Sound 

Recordings Fund (Copyright Owners 

and Featured Recording Artists 

Subfunds) at 3–4 (December 19, 2014 

Order). The Judges now commence a 

proceeding to resolve any existing 

controversies with respect to the 2013 

DART Sound Recordings Fund 

(Copyright Owners and Featured 

Recording Artists subfunds). 

Commencement of Proceeding 

Consistent with 17 U.S.C. 804(b)(8), 

the Judges determine that a controversy 

exists as to the distribution of the 2013 

DART Sound Recordings Fund. The 

Judges make this finding based on the 

fact that AARC notified the Judges that 

it failed to reach settlements with three 

claimants to the 2013 Featured 

Recording Artists Subfund and that it 

failed to reach settlements with five 

claimants to the 2013 Copyright Owners 

Subfund. December 19, 2014 Order at 1. 

In the December 19, 2014 Order, the 

Judges ordered the parties to notify the 

Judges whether any remaining disputes 

in this matter have been resolved. Id. at 

4. To date, the Judges have not received 

notification that any of these 

controversies have been resolved. 

Intention to Conduct a Paper 

Proceeding 

In accordance with Section 

803(b)(5)(B) of the Copyright Act, the 

Judges find it appropriate to conduct a 

paper proceeding in this matter in light 

of the relatively modest amount of 

royalties in dispute and the anticipated 

small number of non-settling claimants. 

In such proceedings, the Judges 

determine issues solely on the basis of 

the filing of a written direct statement 

by each participant, a response of an 

opposing participant, and one 

additional response from the 

participant. 17 U.S.C. 803(b)(5). Any 

party wishing to comment on the 

Judges’ intention to conduct a paper 

proceeding should include such 

comments in its Petition to Participate. 

Petitions to Participate 

Petitions to Participate must provide 

all of the information required by 37 

CFR 351.1(b)(2). Petitions to Participate 

submitted by interested parties whose 

claims do not exceed $1,000 3 must 

contain a statement that the party will 

not seek a distribution of more than 

$1,000. No filing fee is required for 

these parties. Interested parties with 

claims exceeding $1,000, however, must 

submit a filing fee of $150 with their 

Petition to Participate or it will be 

rejected. Cash will not be accepted; 

therefore, parties must pay the filing fee 

with a check or money order made 

payable to the ‘‘Copyright Royalty 

Board.’’ If a check is returned for lack 

of sufficient funds, the corresponding 

Petition to Participate will be dismissed. 

Further procedural matters, including 

scheduling, will be addressed after 

Petitions to Participate and comments, if 

any, on the Judges’ intention to conduct 

a paper proceeding, have been received. 

In accordance with 37 CFR 350.2 

(Representation), only attorneys who are 

members of the bar in one or more states 

and in good standing will be allowed to 

represent parties before the Judges, 

unless the party is an individual who 

represents herself or himself. 

Participants should conform filed 

electronic documents to the Judges’ 

Guidelines for Electronic Documents, 

available online at www.loc.gov/crb/ 

docs/Guidelinesfor_Electronic

_Documents.pdf. 

Dated: March 18, 2015. 

Suzanne M. Barnett, 

Chief U.S. Copyright Royalty Judge. 

[FR Doc. 2015–06678 Filed 3–23–15; 8:45 am] 

BILLING CODE 1410–72–P 

mstockstill on DSK4VPTVN1PROD with NOTICES